Company · Education
University research partner for scientific studies
Dunedin, OS
Every investor coverage indicates participated in a round University of Otago raised.
Companies University of Otago acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming University of Otago. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Vaxxas reports positive Phase I results for its needle-free skin-patch delivery of a measles-rubella vaccine, with Gates Foundation grant funding and a planned PATH-sponsored Phase I/II trial in The Gambia.
Aura Ventures explains why it led Sahha's seed round, citing the health-data gap, Sahha's behavioural-health API, its neuroscience-led team and its University of Otago research partnership.
Cancer biotech Amaroq Therapeutics appointed four experts to its advisory board as it moves toward clinical trials; the New Zealand company's backers include Brandon Capital, which reports $14m invested to date.